Given that IGFBP5 is pro-fibrotic and can be anti- or pro-tumorigenic depending on the cancer subtype, the differentiation status of the cell, TME, and circumstances of activation, studies of this protein should also consider the context in which the protein is functioning and whether it is acting in an IGF dependent or independent manner. This evidence concerns the gene IGF1 and cancer.